Gentian Diagnostics AS (GENT) — Cash Flow-to-Debt Ratio
Gentian Diagnostics AS (GENT) has a Cash Flow-to-Debt Ratio of 0.79x as of December 2025, meaning its operating cash flow of Nkr42.59 Million could theoretically repay 1% of its total liabilities (Nkr53.58 Million) in one year. Check Gentian Diagnostics AS (GENT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gentian Diagnostics AS Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Gentian Diagnostics AS across 13 annual periods. Also explore GENT asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Gentian Diagnostics AS (2013–2025)
Year-by-year debt coverage analysis for Gentian Diagnostics AS. For market capitalisation and broader financial context, see Gentian Diagnostics AS market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | Nkr42.59 Million | Nkr53.58 Million | ▲ +110.4% |
| 2024 | 0.38x | Nkr13.46 Million | Nkr35.61 Million | ▼ -15.9% |
| 2023 | 0.45x | Nkr15.46 Million | Nkr34.40 Million | ▲ +208.3% |
| 2022 | -0.41x | Nkr-13.95 Million | Nkr33.62 Million | ▲ +43.2% |
| 2021 | -0.73x | Nkr-27.05 Million | Nkr37.02 Million | ▼ -288.1% |
| 2020 | -0.19x | Nkr-7.66 Million | Nkr40.69 Million | ▲ +83.4% |
| 2019 | -1.13x | Nkr-21.48 Million | Nkr18.94 Million | ▼ -26.0% |
| 2018 | -0.90x | Nkr-10.90 Million | Nkr12.11 Million | ▲ +57.7% |
| 2017 | -2.13x | Nkr-18.63 Million | Nkr8.75 Million | ▼ -99.8% |
| 2016 | -1.07x | Nkr-7.90 Million | Nkr7.42 Million | ▼ -12.7% |
| 2015 | -0.94x | Nkr-4.63 Million | Nkr4.90 Million | ▼ -475.3% |
| 2014 | -0.16x | Nkr-1.95 Million | Nkr11.88 Million | ▼ -184.7% |
| 2013 | 0.19x | Nkr2.43 Million | Nkr12.55 Million | — |